Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S

被引:43
作者
Olson, JC
Fraylick, JE
McGuffie, EM
Dolan, KM
Yahr, TL
Frank, DW
Vincent, TS
机构
[1] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Expt Oncol, Charleston, SC 29425 USA
[3] Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA
[4] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA
关键词
D O I
10.1128/IAI.67.6.2847-2854.1999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Exoenzyme S (ExoS), an ADP-ribosylating enzyme produced by the opportunistic pathogen Pseudomonas aeruginosa, is directly translocated into eukaryotic cells by bacterial contact. Within the cell, ExoS ADP-ribosylates the cell signaling protein Ras and causes inhibition of DNA synthesis and alterations in cytoskeletal structure. To further understand the interrelationship of the different cellular effects of ExoS, functional analyses were performed on HT-29 epithelial cells after exposure to ExoS-producing P. aeruginosa 388 and the non-ExoS-producing strain 388 Delta S. Two different mechanisms of morphological alteration were identified: (i) a more-transient and less-severe cell rounding caused by the non-ExoS-producing strain 388 Delta S and (ii) a more-severe, long-term cell rounding caused by ExoS-producing strain 388. Long-term effects of ExoS on cell morphology occurred in conjunction with ExoS-mediated inhibition of DNA synthesis and the ADP-ribosylation of pas. ExoS was also found to cause alterations in HT-29 cell function, leading to the loss of cell adhesion and microvillus effacement. Nonadherent ExoS-treated cells remained viable but had a high proportion of modified Ras. While microvillus effacement was detected in both 388- and 388 Delta S-treated cells, effacement was more prevalent and rapid in cells exposed to strain 388. We conclude from these studies that ExoS can have multiple effects on epithelial cell function, with more severe cellular alterations associated with the enzymatic modification of Ras. The finding that ExoS had greater effects on cell growth and adherence than on cell viability suggests that ExoS may contribute to the P. aeruginosa infectious process by rendering cells nonfunctional.
引用
收藏
页码:2847 / 2854
页数:8
相关论文
共 38 条
[21]   PURIFICATION AND CHARACTERIZATION OF EXOENZYME-S FROM PSEUDOMONAS-AERUGINOSA-388 [J].
KULICH, SM ;
FRANK, DW ;
BARBIERI, JT .
INFECTION AND IMMUNITY, 1993, 61 (01) :307-313
[22]  
KULICH SM, 1994, J BIOL CHEM, V269, P10431
[23]   Modification of Ras in eukaryotic cells by Pseudomonas aeruginosa exoenzyme S [J].
McGuffie, EM ;
Frank, DW ;
Vincent, TS ;
Olson, JC .
INFECTION AND IMMUNITY, 1998, 66 (06) :2607-2613
[24]   ISOLATION AND CHARACTERIZATION OF TRANSPOSON-INDUCED MUTANTS OF PSEUDOMONAS-AERUGINOSA DEFICIENT IN PRODUCTION OF EXOENZYME-S [J].
NICAS, TI ;
IGLEWSKI, BH .
INFECTION AND IMMUNITY, 1984, 45 (02) :470-474
[25]   Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos [J].
Nimnual, AS ;
Yatsula, BA ;
Bar-Sagi, D .
SCIENCE, 1998, 279 (5350) :560-563
[26]   Effects of differential expression of the 49-kilodalton exoenzyme S by Pseudomonas aeruginosa on cultured eukaryotic cells [J].
Olson, JC ;
McGuffie, EM ;
Frank, DW .
INFECTION AND IMMUNITY, 1997, 65 (01) :248-256
[27]   Intracellular expression of the ADP-ribosyltransferase domain of Pseudomonas exoenzyme S is cytotoxic to eukaryotic cells [J].
Pederson, KJ ;
Barbieri, JT .
MOLECULAR MICROBIOLOGY, 1998, 30 (04) :751-759
[28]   Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras [J].
RodriguezViciana, P ;
Warne, PH ;
Khwaja, A ;
Marte, BM ;
Pappin, D ;
Das, P ;
Waterfield, MD ;
Ridley, A ;
Downward, J .
CELL, 1997, 89 (03) :457-467
[29]   INTRACELLULAR TARGETING OF THE YERSINIA YOPE CYTOTOXIN IN MAMMALIAN-CELLS INDUCES ACTIN MICROFILAMENT DISRUPTION [J].
ROSQVIST, R ;
FORSBERG, A ;
WOLFWATZ, H .
INFECTION AND IMMUNITY, 1991, 59 (12) :4562-4569
[30]  
SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831